Posts
$GCTS + MaxLinear = Big Small-Cap Semiconductor Catalyst
$GCTS $GCTS just secured a strategic partnership with MaxLinear to develop next-gen 5G FWA and converged gateways. This is not just another PR , this puts GCT directly in the middle of 5G broadband, multi-WAN connectivity and enterprise gateway demand. They’re also showcasing the solution at Computex Taipei, which gives …
The chart setup on $NGTF looks constructive. ✔️ Consolidating after prior momentum ✔️ Near average volume, not panic selling ✔️ Higher lows holding ✔️ Robotics/AI sector momentum heating up again These are often the setups that catch traders off guard once volume returns.
The chart setup on $NGTF looks constructive. ✔️ Consolidating after prior momentum ✔️ Near average volume, not panic selling ✔️ Higher lows holding ✔️ Robotics/AI sector momentum heating up again These are often the setups that catch traders off guard once volume returns.
$EDIT: Post-Offering Fade Setup I’m Watching Today
Ticker: **EDIT** Company: **Editas Medicine** Sector: **Biotech / gene editing** Current setup: **post-offering volatility** Bias: **cautious bearish / fade setup if momentum fails** Offering price: **$2.25** Key level: **$3.50 warrant strike** EDIT is on my watchlist after its public offering. On May 26, Editas priced an underwritten public offering of …
American Fusion - new video - accelerating timeline, securing PPAs, and uplisting imminent
AMFN / American fusion just dropped a huge trove of information 1) In discussions with major data center builders, private equity groups, and "Big Seven" tech firms to secure Power Purchase Agreements 2) The 10th prototype, a 5-megawatt pre-production model, will be internationally validated net fusion by the end of …
RXRX Update: Yesterday’s Thesis Got Pushback — Here’s Where I Stand Today
Ticker: **RXRX** Current area: **around $2.97** Bias: **still bearish short-term, but not blindly bearish** Primary downside target: **$2.70** Stretch target: **$2.50–$2.60** Invalidation: **reclaim and hold above $3.25–$3.35** Yesterday’s RXRX post got a lot of attention, so I want to tighten the thesis and address the biggest pushback directly. The fair …
The Lounge
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
LFVN pt 3 - Just the beginning?
Hey all. quick update, since we're seeing some significant movement. [Last Friday's data](https://preview.redd.it/xblf3glcpl3h1.png?width=3803&format=png&auto=webp&s=16fec9ae4998fb4d0c1511d713ec166f8b23bf19) [Live data \(could be buggy\)](https://preview.redd.it/uh64r5qgpl3h1.png?width=1908&format=png&auto=webp&s=d65633899b60a8c9a52d7a9aba53fc2e3c71bf51) A few weeks ago I posted a follow-up saying LFVN’s earnings were poor, but the potential was still there since there was a strong floor at $5. With the cost-to-borrow being extremely …
Quantum Computing Infrastructure Play: 100x Potential
Like many, I’m extremely bullish about the future of quantum stocks- we now have the US government pouring millions into the ecosystem as countries race towards building the most advanced quantum technology. For anyone who is interested in ‘Neutral Atom Quantum Computing’ (AKA exactly what Infleqtion **$INFQ** is doing) there …
The Value Thesis for $TLF
Look, I know everyone is currently chasing secret tier 1 and tier 2 suppliers for a certain rocket company. Attempting to ride space microcaps and piggyback off the highest valued public offering in history, but what if I told you there was a play where the math protects your downside …
$HOLO Looks Like a Textbook Reverse Split + Convertible Note Dilution Case — Recent Filing Red Flags
I am writing to share serious allegations of potential market manipulation, dilution abuse, and shareholder rights violations involving MicroCloud Hologram Inc. (Ticker: HOLO), a Nasdaq-listed company. Over the past 24 months, the company has: \- Executed multiple reverse stock splits (1:10 in Feb 2024, 1:20 in Oct 2024, 1:40 in …